| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.58 | 0.03 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.35 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |